Related references
Note: Only part of the references are listed.Epidemiology, outcomes and validation of RIFLE and AKIN criteria in acute kidney injury (AKI) in critically ill patients: Indian perspective
N. Pavan Kumar Reddy et al.
RENAL FAILURE (2014)
Kidney Volume and Functional Outcomes in Autosomal Dominant Polycystic Kidney Disease
Arlene B. Chapman et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Comparison of Risk Prediction Using the CKD-EPI Equation and the MDRD Study Equation for Estimated Glomerular Filtration Rate
Kunihiro Matsushita et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Analysis of baseline parameters in the HALT polycystic kidney disease trials
Vicente E. Torres et al.
KIDNEY INTERNATIONAL (2012)
Changes in causes of death and risk of cancer in Danish patients with autosomal dominant polycystic kidney disease and end-stage renal disease
Bjarne Orskov et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Hypertension and Autosomal Dominant Polycystic Kidney Disease
Robert W. Schrier
AMERICAN JOURNAL OF KIDNEY DISEASES (2011)
Use of Antihypertensive Medications and Mortality of Patients With Autosomal Dominant Polycystic Kidney Disease: A Population-Based Study
Christine Patch et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2011)
Improved Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease in Denmark
Bjarne Orskov et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
The HALT Polycystic Kidney Disease Trials: Design and Implementation
Arlene B. Chapman et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Chronic treatment with lisinopril decreases proliferative and apoptotic pathways in autosomal recessive polycystic kidney disease
Guangfu Jia et al.
PEDIATRIC NEPHROLOGY (2010)
Aldosterone as a renal growth factor
Warren Thomas et al.
STEROIDS (2010)
MRI-based Kidney Volume Measurements in ADPKD: Reliability and Effect of Gadolinium Enhancement
Kyongtae T. Bae et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Autosomal dominant polycystic kidney disease: the last 3 years
Vicente E. Torres et al.
KIDNEY INTERNATIONAL (2009)
Autosomal dominant polycystic kidney disease
Jared J. Grantham
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effect of statin and angiotensin-converting enzyme inhibition on structural and hemodynamic alterations in autosomal dominant polycystic kidney disease model
Iram Zafar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Volume progression in polycystic kidney disease
JJ Grantham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Volume progression in autosomal dominant polycystic kidney disease: The major factor determining clinical outcomes
Jared J. Grantham et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Epidemiological study of kidney survival in autosomal dominant polycystic kidney disease
RW Schrier et al.
KIDNEY INTERNATIONAL (2003)
Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: Results of a seven-year prospective randomized study
R Schrier et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Share Paper
